Reduced expression of SNF5 is also observed in synovial sarcoma [50], [51], and, interestingly, FGFR pathway inhibition exerts anti-proliferative effects in synovial sarcoma models [52]. The gene discussed is SMARCB1; the disease is synovial sarcoma.